Ownership history in Prosight Management, LP · 7 quarters on record
This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in SYNDAX PHARMACEUTICALS INC (SNDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 665,000 | -338,400 | -33.7% | 2.89% | $14.0M | $21.01 |
| 2025 Q3 | REDUCED | 1,003,400 | -76,273 | -7.1% | 3.60% | $15.4M | $15.39 |
| 2025 Q2 | ADDED | 1,079,673 | +470,421 | +77.2% | 2.47% | $10.1M | $9.36 |
| 2025 Q1 | REDUCED | 609,252 | -10,748 | -1.7% | 2.46% | $7.5M | $12.28 |
| 2024 Q4 | ADDED | 620,000 | +65,897 | +11.9% | 2.27% | $8.2M | $13.22 |
| 2024 Q3 | ADDED | 554,103 | +2,559 | +0.5% | 2.62% | $10.7M | $19.25 |
| 2024 Q2 | INITIATED | 551,544 | — | — | 3.38% | $11.3M | — |
As of 2025 Q4 — sorted by position size